Prevention and treatment of radiation-induced lung injury

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Avanzo M, Barbiero S, Trovo M et al. Voxel-by-voxel correlation between radiologically radiation induced lung injury and dose after image-guided, intensity modulated radiotherapy for lung tumors. Physica Medica 42, 150–156 (2017).
  MedlineGoogle Scholar
• 2. Jenkins P, Welsh A. Computed tomography appearance of early radiation injury to the lung: correlation with clinical and dosimetric factors. Int. J. Radiat. Oncol. Biol. Phys. 81(1), 97–103 (2011).
  MedlineGoogle Scholar
• 3. Linda A, Trovo M, Bradley JD. Radiation injury of the lung after stereotactic body radiation therapy (SBRT) for lung cancer: a timeline and pattern of CT changes. Eur. J. Radiol. 79(1), 147–154 (2011).
  MedlineGoogle Scholar
• 4. D'Agostino GR, De Rose F, Balducci M et al. PO-0679: radiation-induced lung injury (RILI): correlation with dosimetric parameters and pulmonary function. Radiat. Oncol. 106, S261 (2013).
  Google Scholar
• 5. Xu Hm CJ. Management and outcome of symptomatic radiation induced lung injury in non-small cell lung cancer. Chin. J. Radiat. Oncol. 22(3), 201–204 (2013).
  Google Scholar
• 6. Sekine I, Sumi M, Ito Y et al. Retrospective analysis of steroid therapy for radiation-induced lung injury in lung cancer patients. Radiother. Oncol. 80(1), 93–97 (2006).
  Medline CASGoogle Scholar
• 7. Sun Y, Du YJ, Zhao H, Zhang GX, Sun N, Li XJ. Protective effects of ulinastatin and methylprednisolone against radiation-induced lung injury in mice. J. Radiat. Res. 57(5), 505–511 (2016).
  Medline CASGoogle Scholar
• 8. Henkenberens C, Janssen S, Lavae-Mokhtari M et al. Inhalative steroids as an individual treatment in symptomatic lung cancer patients with radiation pneumonitis grade II after radiotherapy – a single-centre experience. Radiat. Oncol. 11, 12 (2016).
  Medline CASGoogle Scholar
• 9. Mangoni M, Sottili M, Gerini C et al. A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model. Lung Cancer 90(3), 405–409 (2015).
  MedlineGoogle Scholar
• 10. Nicola T, Ambalavanan N, Zhang W et al. Hypoxia-induced inhibition of lung development is attenuated by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Am. J. Physiol. Lung Cell Mol. Physiol. 301(1), L125–L134 (2011). • The treatment agents were safe. Animal study indicated that the drugs contributed to the TGF-β signaling inhibition and development of alveolus.
  Medline CASGoogle Scholar
• 11. Deng YL, Xiong XZ, Cheng NS. Organ fibrosis inhibited by blocking transforming growth factor-beta signaling via peroxisome proliferator-activated receptor gamma agonists. HBPD Int. 11(5), 467–478 (2012).
  CASGoogle Scholar
• 12. Burgess HA, Daugherty LE, Thatcher TH et al. PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol. 288(6), L1146–L1153 (2005).
  Medline CASGoogle Scholar
• 13. Sime PJ. The antifibrogenic potential of PPARgamma ligands in pulmonary fibrosis. JIM 56(2), 534–538 (2008).
  CASGoogle Scholar
• 14. Ferguson HE, Kulkarni A, Lehmann GM et al. Electrophilic peroxisome proliferator-activated receptor-gamma ligands have potent antifibrotic effects in human lung fibroblasts. Am. J. Resp. Cell. Mol. 41(6), 722–730 (2009).
  Medline CASGoogle Scholar
• 15. Leem AY, Shin MH, Douglas IS et al. All-trans retinoic acid attenuates bleomycin-induced pulmonary fibrosis via downregulating EphA2-EphrinA1 signaling. Biochem. Biophys. Res. Commun. 491(3), 721–726 (2017).
  Medline CASGoogle Scholar
• 16. Tabata C, Kadokawa Y, Tabata R et al. All-trans-retinoic acid prevents radiation- or bleomycin-induced pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 174(12), 1352–1360 (2006).
  Medline CASGoogle Scholar
• 17. Dong Z, Tai W, Yang Y et al. The role of all-trans retinoic acid in bleomycin-induced pulmonary fibrosis in mice. Exp. Lung Res. 38(2), 82–89 (2012).
  Medline CASGoogle Scholar
• 18. Song X, Liu W, Xie S et al. All-trans retinoic acid ameliorates bleomycin-induced lung fibrosis by downregulating the TGF-beta1/Smad3 signaling pathway in rats. Lab. Invest. 93(11), 1219–1231 (2013).
  Medline CASGoogle Scholar
• 19. Segel MJ, Or R, Tzurel A et al. All-trans-retinoic acid (ATRA) is of no benefit in bleomycin-induced lung injury. Pulm. Pharmacol. Ther. 14(5), 403–407 (2001).
  Medline CASGoogle Scholar
• 20. Bao P, Gao W, Li S et al. Effect of pretreatment with high-dose ulinastatin in preventing radiation-induced pulmonary injury in rats. Eur. J. Pharmacol. 603(1-3), 114–119 (2009).
  Medline CASGoogle Scholar
• 21. Wu J, Yan X, Jin G. Ulinastatin protects rats from sepsis-induced acute lung injury by suppressing the JAK-STAT3 pathway. J. Cell. Biochem. doi: 10.1002/jcb.27550 (.2018) (Epub ahead of print).
  Google Scholar
• 22. Li D, Ji H, Zhao B et al. Therapeutic effect of ulinastatin on pulmonary fibrosis via downregulation of TGFbeta1, TNFalpha and NFkappaB. Mol. Med. Rep. 17(1), 1717–1723 (2018).
  Medline CASGoogle Scholar
• 23. Ren B, Wu H, Zhu J et al. Ulinastatin attenuates lung ischemia-reperfusion injury in rats by inhibiting tumor necrosis factor alpha. Transplant. Proc. 38(9), 2777–2779 (2006).
  Medline CASGoogle Scholar
• 24. Molthen RC, Wu Q, Fish BL, Moulder JE, Jacobs ER, Medhora MM. Mitigation of radiation induced pulmonary vascular injury by delayed treatment with captopril. Respirology 17(8), 1261–1268 (2012).
  MedlineGoogle Scholar
• 25. Medhora M, Gao F, Jacobs ER, Moulder JE. Radiation damage to the lung: mitigation by angiotensin-converting enzyme (ACE) inhibitors. Respirology 17(1), 66–71 (2012). •• ACEI is the first and most effective alleviator. ACE is rich in the lung tissues. These bring hope for the attenuation of RILI.
  MedlineGoogle Scholar
• 26. Kharofa J, Cohen EP, Tomic R, Xiang Q, Gore E. Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 84(1), 238–243 (2012).
  Medline CASGoogle Scholar
• 27. Molteni A, Wolfe LF, Ward WF et al. Effect of an angiotensin II receptor blocker and two angiotensin converting enzyme inhibitors on transforming growth factor-beta (TGF-beta) and alpha-actomyosin (alpha SMA), important mediators of radiation-induced pneumopathy and lung fibrosis. Curr. Pharm. Des. 13(13), 1307–1316 (2007).
  Medline CASGoogle Scholar
• 28. Bracci S, Valeriani M, Agolli L, De Sanctis V, Maurizi Enrici R, Osti MF. Renin-angiotensin system inhibitors might help to reduce the development of symptomatic radiation pneumonitis after stereotactic body radiotherapy for lung cancer. Clin. Lung Cancer 17(3), 189–197 (2016).
  Medline CASGoogle Scholar
• 29. Wang H, Liao Z, Zhuang Y et al. Do angiotensin-converting enzyme inhibitors reduce the risk of symptomatic radiation pneumonitis in patients with non-small cell lung cancer after definitive radiation therapy? Analysis of a single-institution database. Int. J. Radiat. Oncol. Biol. Phys. 87(5), 1071–1077 (2013).
  Medline CASGoogle Scholar
• 30. Kawamura K, Ichikado K, Yasuda Y, Anan K, Suga M. Azithromycin for idiopathic acute exacerbation of idiopathic pulmonary fibrosis: a retrospective single-center study. BMC Pulm. Med. 17(1), 94 (2017).
  MedlineGoogle Scholar
• 31. Liu Y, Pu Y, Li D, Zhou L, Wan L. Azithromycin ameliorates airway remodeling via inhibiting airway epithelium apoptosis. Life Sci. 170, 1–8 (2017).
  MedlineGoogle Scholar
• 32. Kawamura K, Ichikado K, Suga M, Yoshioka M. Efficacy of azithromycin for treatment of acute exacerbation of chronic fibrosing interstitial pneumonia: a prospective, open-label study with historical controls. Respiration 87(6), 478–484 (2014).
  Medline CASGoogle Scholar
• 33. Banerjee B, Musk M, Sutanto EN et al. Regional differences in susceptibiity of bronchial epithelium to mesenchymal transition and inhibition by the macrolide antibiotic azithromycin. PloS ONE 7(12), e52309 (2012).
  Medline CASGoogle Scholar
• 34. Tang F, Li R, Xue J et al. Azithromycin attenuates acute radiation-induced lung injury in mice. Oncol. Lett. 14(5), 5211–5220 (2017). •• Azithromycin could attenuate RILI through anti-inflammatory and antifibrotic effects, with satisfactory safety.
  MedlineGoogle Scholar
• 35. Liu Y, Yu H, Zhang C et al. Protective effects of berberine on radiation-induced lung injury via intercellular adhesion molecular-1 and transforming growth factor-beta-1 in patients with lung cancer. Eur. J. Cancer 44(16), 2425–2432 (2008).
  Medline CASGoogle Scholar
• 36. Liang Y, Fan C, Yan X et al. Berberine ameliorates lipopolysaccharide-induced acute lung injury via the PERK-mediated Nrf2/HO-1 signaling axis. 33(1), 130–148 (2019).
  Google Scholar
• 37. Choi SB, Bae GS, Jo IJ, Song HJ, Park SJ. Effects of berberine on acute necrotizing pancreatitis and associated lung injury. Pancreas 46(8), 1046–1055 (2017).
  Medline CASGoogle Scholar
• 38. Chitra P, Saiprasad G, Manikandan R, Sudhandiran G. Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-kappaB dependant TGF-beta activation: a biphasic experimental study. Toxicol. Lett. 219(2), 178–193 (2013).
  Medline CASGoogle Scholar
• 39. Niu X, Liu F, Li W et al. Cavidine ameliorates lipopolysaccharide-induced acute lung injury via NF-kappaB signaling pathway in vivo and in vitro. Inflammation 40(4), 1111–1122 (2017).
  Medline CASGoogle Scholar
• 40. Yu X, Yu S, Chen L et al. Tetrahydroberberrubine attenuates lipopolysaccharide-induced acute lung injury by down-regulating MAPK, AKT, and NF-kappaB signaling pathways. Biomed. Pharmacother. 82, 489–497 (2016).
  Medline CASGoogle Scholar
• 41. Wang L, Shan Y, Ye Y et al. COX-2 inhibition attenuates lung injury induced by skeletal muscle ischemia reperfusion in rats. Int. Immunopharmacol. 31, 116–122 (2016).
  Medline CASGoogle Scholar
• 42. Gore E. Celecoxib and radiation therapy in non-small-cell lung cancer. Oncology (Williston Park, N.Y.) 18(Suppl. 14), 10–14 (2004).
  MedlineGoogle Scholar
• 43. Xu XT, Hu WT, Zhou JY, Tu Y. Celecoxib enhances the radiosensitivity of HCT116 cells in a COX-2 independent manner by up-regulating BCCIP. Am. J. Transl. Res. 9(3), 1088–1100 (2017).
  Medline CASGoogle Scholar
• 44. Shin YK, Park JS, Kim HS et al. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels. Cancer Res. 65(20), 9501–9509 (2005). •• Celecoxib showed synergistic effects on radiation, and it also contributed to the repair of RILI.
  Medline CASGoogle Scholar
• 45. Park W, Oh YT, Han JH, Pyo H. Antitumor enhancement of celecoxib, a selective cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing cyclooxygenase-2. J. Exp. Clin. Cancer Res. CR 27, 66 (2008).
  MedlineGoogle Scholar
• 46. Hunter NR, Valdecanas D, Liao Z, Milas L, Thames HD, Mason KA. Mitigation and treatment of radiation-induced thoracic injury with a cyclooxygenase-2 inhibitor, celecoxib. Int. J. Radiat. Oncol. Biol. Phys. 85(2), 472–476 (2013).
  Medline CASGoogle Scholar
• 47. Scully M, Gang C, Condron C, Bouchier-Hayes D, Cunningham AJ. Protective role of cyclooxygenase (COX)-2 in experimental lung injury: evidence of a lipoxin A4-mediated effect. J. Surg. Res. 175(1), 176–184 (2012).
  Medline CASGoogle Scholar
• 48. Fukunaga K, Kohli P, Bonnans C, Fredenburgh LE, Levy BD. Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury. J. Immunol. Res. 174(8), 5033–5039 (2005).
  CASGoogle Scholar
• 49. Calik M, Yavas G, Calik SG et al. Amelioration of radiation-induced lung injury by halofuginone: an experimental study in Wistar-Albino rats. Hum. Exp. Toxicol. 36(6), 638–647 (2017).
  Medline CASGoogle Scholar
• 50. Luo Y, Xie X, Luo D, Wang Y, Gao Y. The role of halofuginone in fibrosis: more to be explored? J. Leukoc. Biol. 102(6), 1333–1345 (2017).
  Medline CASGoogle Scholar
• 51. Yavas G, Calik M, Calik G, Yavas C, Ata O, Esme H. The effect of halofuginone in the amelioration of radiation induced-lung fibrosis. Med. Hypotheses 80(4), 357–359 (2013). •• Halofuginone showed protective effects against radiation-induced soft tissue fibrosis. Its antifibrotic mechanism is suitable for the radiation fibrosis of lung, which may be effective for treating pulmonary fibrosis.
  Medline CASGoogle Scholar
• 52. Xavier S, Piek E, Fujii M et al. Amelioration of radiation-induced fibrosis: inhibition of transforming growth factor-beta signaling by halofuginone. J. Biol. Chem. 279(15), 15167–15176 (2004).
  Medline CASGoogle Scholar
• 53. Pines M, Nagler A. Halofuginone: a novel antifibrotic therapy. Gen. Pharmacol. 30(4), 445–450 (1998).
  Medline CASGoogle Scholar
• 54. Pines M. Halofuginone for fibrosis, regeneration and cancer in the gastrointestinal tract. World J. Gastroenterol. 20(40), 14778–14786 (2014).
  Medline CASGoogle Scholar
• 55. Tzurel A, Segel MJ, Or R, Goldstein RH, Breuer R. Halofuginone does not reduce fibrosis in bleomycin-induced lung injury. Life Sci. 71(14), 1599–1606 (2002).
  Medline CASGoogle Scholar
• 56. Liu B, Tang Y, Yi M et al. Genetic variants in the plasminogen activator inhibitor-1 gene are associated with an increased risk of radiation pneumonitis in lung cancer patients. Cancer Med. 6(3), 681–688 (2017).
  Medline CASGoogle Scholar
• 57. Lavigne J, Soysouvanh F, Buard V et al. Conditional Plasminogen Activator Inhibitor Type 1 deletion in the endothelial compartment has no beneficial effect on radiation-induced whole-lung damage in mice. Int. J. Radiat. Oncol. Biol. Phys. 99(4), 972–982 (2017).
  Medline CASGoogle Scholar
• 58. Chung EJ, Mckay-Corkum G, Chung S et al. Truncated Plasminogen Activator Inhibitor-1 protein protects from pulmonary fibrosis mediated by irradiation in a murine model. Int. J. Radiat. Oncol. Biol. Phys. 94(5), 1163–1172 (2016).
  Medline CASGoogle Scholar
• 59. Deng H, Gao X, Peng H et al. Effect of liposomemediated HSP27 transfection on collagen synthesis in alveolar type II epithelial cells. Mol. Med. Rep. 17(5), 7319–7324 (2018).
  Medline CASGoogle Scholar
• 60. Xia C, Chang P, Zhang Y et al. Therapeutic effects of bone marrow-derived mesenchymal stem cells on radiation-induced lung injury. Oncol. Rep. 35(2), 731–738 (2016).
  Medline CASGoogle Scholar
• 61. Hao Y, Ran Y, Lu B et al. Therapeutic effects of human umbilical cord-derived mesenchymal stem cells on canine radiation-induced lung injury. Int. J. Radiat. Oncol. Biol. Phys. 102(2), 407–416 (2018).
  MedlineGoogle Scholar
• 62. Klein D, Schmetter A, Imsak R et al. Therapy with multipotent mesenchymal stromal cells protects lungs from radiation-induced injury and reduces the risk of lung metastasis. Antioxid. Redox. Signal. 24(2), 53–69 (2016). •• Theauthors proposed a new concept that radiation-induced injury of pulmonary vessels contributed to the pulmonary metastasis. Mesenchymal stem cells could inhibit the metastasis by attenuating the vascular injury.
  Medline CASGoogle Scholar
• 63. Chen QH, Liu AR, Qiu HB, Yang Y. Interaction between mesenchymal stem cells and endothelial cells restores endothelial permeability via paracrine hepatocyte growth factor in vitro. Stem. Cell Res. Ther. 6, 44 (2015).
  MedlineGoogle Scholar
• 64. Cahill EF, Kennelly H, Carty F, Mahon BP, English K. Hepatocyte growth factor is required for mesenchymal stromal cell protection against bleomycin-induced pulmonary fibrosis. Stem Cells Transl. Med. 5(10), 1307–1318 (2016).
  Medline CASGoogle Scholar
• 65. Ionescu L, Byrne RN, Van Haaften T et al. Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action. Am. J. Physiol. Lung C 303(11), L967–977 (2012).
  Medline CASGoogle Scholar
• 66. Li J, Zhou J, Zhang D, Song Y, She J, Bai C. Bone marrow-derived mesenchymal stem cells enhance autophagy via PI3K/AKT signalling to reduce the severity of ischaemia/reperfusion-induced lung injury. J. Cell. Mol. Med. 19(10), 2341–2351 (2015).
  Medline CASGoogle Scholar
• 67. Nicolay NH, Lopez Perez R, Debus J, Huber PE. Mesenchymal stem cells – a new hope for radiotherapy-induced tissue damage? Cancer Lett. 366(2), 133–140 (2015).
  Medline CASGoogle Scholar
• 68. Haiping Z, Takayama K, Uchino J et al. Prevention of radiation-induced pneumonitis by recombinant adenovirus-mediated transferring of soluble TGF-beta type II receptor gene. Cancer Gene Ther. 13(9), 864–872 (2006).
  Medline CASGoogle Scholar
• 69. Anscher MS, Thrasher B, Rabbani Z, Teicher B, Vujaskovic Z. Antitransforming growth factor-beta antibody 1D11 ameliorates normal tissue damage caused by high-dose radiation. Int. J. Radiat. Oncol. Biol. Phys. 65(3), 876–881 (2006).
  Medline CASGoogle Scholar
• 70. Shin D, Lee G. Adenovirus-mediated FOXP3 expression in lung epithelial cells ameliorates acute radiation-induced pneumonitis in mice. Gene Ther. 24(2), 104–112 (2017). •• FOXP3 overexpression inhibited the recruitment of the inflammatory cells and the deposit of collagen, which brings hope for treating RILI by gene therapy.
  Medline CASGoogle Scholar
• 71. Zhang X, Hadley C, Jackson IL et al. Hypo-CpG methylation controls PTEN expression and cell apoptosis in irradiated lung. Free Radic. Res. 50(8), 875–886 (2016).
  Medline CASGoogle Scholar
• 72. Zhang Y, Zhang X, Rabbani ZN, Jackson IL, Vujaskovic Z. Oxidative stress mediates radiation lung injury by inducing apoptosis. Int. J. Radiat. Oncol. Biol. Phys. 83(2), 740–748 (2012).
  Medline CASGoogle Scholar
• 73. Rubio L, Annangi B, Vila L, Hernandez A, Marcos R. Antioxidant and anti-genotoxic properties of cerium oxide nanoparticles in a pulmonary-like cell system. Arch. Toxicol. 90(2), 269–278 (2016).
  Medline CASGoogle Scholar
• 74. Ko JW, Lee HJ,Shin NR et al. Silicon dioxide nanoparticles enhance endotoxin-induced lung injury in mice. Molecules 23 (.9), 2247 (2018).
  Google Scholar
• 75. Serebrovska Z, Swanson RJ, Portnichenko V et al. Anti-inflammatory and antioxidant effect of cerium dioxide nanoparticles immobilized on the surface of silica nanoparticles in rat experimental pneumonia. Biomed. Pharmacother. 92, 69–77 (2017).
  Medline CASGoogle Scholar
• 76. Vujaskovic Z, Xu P, Maidment B et al. Cerium oxide nanoparticles protect lung from radiation-induced injury in CBA/J mice. Int. J. Radiat. Oncol. Biol. Phys. 84(3), S683–S683 (2012).
  Google Scholar
• 77. Xu PT, Maidment BW 3rd, Antonic V et al. Cerium oxide nanoparticles: a potential medical countermeasure to mitigate radiation-induced lung injury in CBA/J mice. Radiat. Res. 185(5), 516–526 (2016). •• CNPs showed surface regenerative capacity and could effectively control the active oxygen and nitrogen. CNPs showed protective effects against the RILI by lethal dose. It may serve as a novel option for treating RILI.
  Medline CASGoogle Scholar